Last updated on 1 Jul 2020
Owner Info
Inheris Biopharma, Inc. incorporated in the State of Delaware
150 North Riverside Plaza, Suite 1840, Chicago
Illinois, 60606 UNITED STATES OF AMERICA,
Serial Number
2052952 filed on 22 Nov 2019
Correspondent
Spruson & Ferguson
GPO Box 3898,
Sydney, NSW, 2001 AUSTRALIA,
2052952
22 Nov 2019
22 Nov 2029
WORD
24 May 2019
US
Status Date | Action Taken |
---|---|
1st Jul 2020 | IP Right Registered correspondence sent |
30th Jun 2020 | IP Right Registration Published |
30th Jun 2020 | Status change to Registered/Protected |
23rd Apr 2020 | Application Accepted correspondence sent |
23rd Apr 2020 | IP Right has been Examined |
23rd Apr 2020 | IP Right Acceptance Published |
30th Nov 2019 | Early Acceptance Notice correspondence sent |
29th Nov 2019 | Status change to Accepted |
29th Nov 2019 | Awaiting examination |
29th Nov 2019 | Examination expedited |